FMR LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 2.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,208,281 shares of the company's stock after selling 118,741 shares during the period. FMR LLC owned approximately 1.74% of Cardinal Health worth $497,713,000 as of its most recent filing with the SEC.
Other institutional investors have also recently modified their holdings of the company. Unigestion Holding SA raised its position in shares of Cardinal Health by 614.4% in the 4th quarter. Unigestion Holding SA now owns 46,510 shares of the company's stock valued at $5,501,000 after buying an additional 40,000 shares in the last quarter. Federated Hermes Inc. increased its stake in shares of Cardinal Health by 55.2% in the fourth quarter. Federated Hermes Inc. now owns 578,367 shares of the company's stock valued at $68,403,000 after buying an additional 205,818 shares during the period. Aster Capital Management DIFC Ltd bought a new position in shares of Cardinal Health during the fourth quarter valued at $685,000. Wedbush Securities Inc. bought a new position in Cardinal Health during the 4th quarter worth $550,000. Finally, Sit Investment Associates Inc. lifted its stake in shares of Cardinal Health by 81.2% in the fourth quarter. Sit Investment Associates Inc. now owns 92,735 shares of the company's stock worth $10,968,000 after acquiring an additional 41,545 shares during the period. 87.17% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of brokerages recently weighed in on CAH. Mizuho lifted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research note on Monday, March 31st. JPMorgan Chase & Co. boosted their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Citigroup boosted their price target on Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research note on Friday, January 10th. Finally, Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective for the company in a research report on Tuesday, January 7th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $140.86.
View Our Latest Report on CAH
Cardinal Health Trading Down 0.4 %
Shares of CAH traded down $0.58 on Tuesday, reaching $134.20. The company's stock had a trading volume of 801,068 shares, compared to its average volume of 2,177,762. The stock has a market capitalization of $32.42 billion, a PE ratio of 25.02, a PEG ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $139.50. The firm has a fifty day moving average of $129.48 and a 200-day moving average of $122.66.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's payout ratio is 37.69%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
